From: Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study
 | Mean ± SD | |
Complete Blood Count (CBC) | ||
 Hemoglobin (g/dl) | 14.2 ± 1.8 | |
 White blood cells (/μL) | 7.3 ± 2.4 × 103 | |
 Platelets (/μl) | 288 ± 64 × 103 | |
Liver function | ||
 ALT (IU/L) Normal range (7–56 IU/L) | 29.8 ± 26.5 | |
 AST (IU/L) Normal range (5–40 IU/L) | 33.1 ± 32.2 | |
Renal function | ||
 Urea (mg/dl) Normal range (5–20 mg/dl) | 14.5 ± 6.4 | |
 Creatinine (μmol/L) Normal range (60 to 110 μmol/L) | 73.6 ± 27.4 | |
Glucose | ||
 Random Blood glucose (mmol/l) Normal range (3.9–5.6 mmol/l) | 5.1 ± 0.8 | |
Abnormality | Number of cases | Percentage |
  Cases with anemia | 6 | 12% |
  Cases with leucocytosis | 5 | 10% |
  Cases with leukopenia | 3 | 6% |
  Cases with elevated liver function | 4 | 8% |
  Cases with elevated Kidney function | 2 | 4% |
Serology | ||
 Positive Hepatitis C | 11 | 22% |
 Positive HIV | 2 | 4% |